𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A survey of the effectiveness of cyclophosphamide in patients with severe aplastic anemia

✍ Scribed by Dr. Paul F. Griner


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
402 KB
Volume
8
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High-dose cyclophosphamide in the treatm
✍ JosΓ© Carlos Jaime-PΓ©rez; Oscar GonzΓ‘lez-Llano; David GΓ³mez-Almaguer πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article

Treatment of platelet-alloimmunization w
✍ Masahiro Yamamoto; Hiroshi Ideguchi; Junji Nishimura; Hajime Nawata; Shoichi Ina πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 1 views

The development of alloantibodies to platelets is a major problem in the supportive management of thrombocytopenia in patients with severe aplastic anemia. We report here a case of aplastic anemia refractory to platelet transfusion. An immunosuppressant, cyclosporin A, which was used for the therapy

Effect of androgen therapy and anemia on
✍ Piedras, Josefa; HernΓ‘ndez, Guadalupe; LΓ³pez-Karpovitch, Xavier πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 1 views

Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.